期刊文献+

聚焦解决模式对肿瘤合并尿毒症血液透析患者高磷血症的控制研究 被引量:8

Study on the control of hyperphosphatemia in hemodialysis patients with tumor complicated with uremia by focused resolution model
原文传递
导出
摘要 目的探讨聚焦解决模式对肿瘤合并尿毒症血液透析患者高磷血症的控制效果。方法 72例肿瘤合并尿毒症血液透析患者按照随机数字表法分为对照组和观察组,各36例,对比护理干预后两组患者的血磷水平、生存质量等。结果观察组干预后的钙磷乘积、血磷水平均显著低于对照组(P<0.05)。观察组的功能领域、总体生存质量评分均显著高于对照组(P<0.05)。结论聚焦解决模式能有效降低肿瘤合并尿毒症血液透析患者的血磷水平,改善其生存质量。 OBJECTIVE To explore the control effect of focusing solution on hyperphosphatemia in hemodialysis patients with tumor complicated with uremia.METHODS 72 cases of hemodialysis patients with tumor and uremia were divided into control group and observation group according to the random number table method.RESULTS After intervention,the calcium and phosphorus product and serum phosphorus levels of the observation group were significantly lower than those of the control group(P<0.05).The scores of functional areas and overall quality of life of the observation group were significantly higher than those of the control group(P<0.05).CONCLUSIONS Focusing treatment can effectively reduce the level of serum phosphorus and improve the quality of life of hemodialysis patients with tumor complicated with uremia.
作者 康娜 王志英 常婧 KANG Na;WANG Zhi-ying;CHANG Jing(Chinese People's Liberation Army General Hospital,Beijing100853,P.R.China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2018年第S2期217-218,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 聚焦解决模式 肿瘤 高磷血症 尿毒症血液透析 focus resolution model tumor hyperphosphatemia uremia hemodialysis
  • 相关文献

参考文献4

二级参考文献47

  • 1骆宏,叶志弘,王菊香.聚焦解决模式在临床护理中的应用[J].中华护理杂志,2007,42(6):568-570. 被引量:267
  • 2G aasbeek A,Meinders E.Hypophosphatemia:An update on its etiology and treatment[J].Am J Med,2005,118:1094-1101.
  • 3Tentori F.Mineral and bone disorder and outcomes in hemodialysis patients:results from the DOPPS[J].Semin Dial,2010,23:10-14.
  • 4Kong X,Zhang L,Zhang L,et al.Mineral and bone disorder in Chinese dialysis patients:a multicenter study[J].BMC Nephrol,2012,21:116.
  • 5Palmer SC,Hayen A,Macaskill P,et al.Serum levels of phosphorus,parathyroid hormone,and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease:a systematic review and meta-analysis[J].JAMA,2011,305:1119-1127.
  • 6Floege J,Kim J,Ireland E,et al.Serum iPTH,calcium and phosphate,and the risk of mortality in a European haemodialysis population[J].Nephrol Dial Transplant,2011,26:1948-1955.
  • 7Slatopolsky E,Moe S.50 years of research and discovery in chronic kidney disease and mineral & bone disorder:the central role of phosphate[J].Kidney Int Suppl,2011,121:S1-S2.
  • 8Danese MD,Belozeroff V,Smirnakis K,et al.Consistent control of mineral and bone disorder in incident hemodialysis patients[J].Clin J Am Soc Nephrol,2008,3:1423-1429.
  • 9Kidney Disease:Improving Global Outcomes (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J].Kidney International 2009,76 (Suppl 113):S1-S130.
  • 10Pierratos A.Nocturnal home haemodialysis:an update on a 5-year experience[J].Nephrol Dial Transplant,1999,14:2835-2840.

共引文献71

同被引文献114

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部